FDA 483 - Avantec Vascular Corporation - January 26, 2023

An FDA inspection of Avantec Vascular Corporation in Sunnyvale, CA, from January 23-26, 2023, revealed one observation. The firm's procedures for ensuring routine equipment maintenance were found to be inadequately established. This deficiency was specifically noted with a temperature controller that was overdue for preventive maintenance.